Geraldine Byrne Nason

Geraldine Byrne Nason

Total lobbying returns involving this official: 36

Connections GraphMethod Pie

Official Profile

Most Recent Title
Ambassador
Most Recent Public Body
Department of Foreign Affairs
First Seen
18 January 2016
Last Seen
21 September 2026

Observed Titles

AmbassadorSecond Secretary General

Observed Public Bodies

Department of Foreign Affairs

Current Oireachtas Committee Memberships

No current committee memberships matched for this official.

All Lobbyists
Select methods...

Lobbying Records (Page 1 of 4)

daa plc

1 official
2026-09-21

Intent: To inform the Ambassador that daa International has been named preferred bidder for Dulles VIP terminal design, construction and 20-year operation, pending approval, and to express thanks for support and advice.

Details: Letter to Ambassador with thanks and project update.

Methods
Letter

Pfizer

5 officials
2026-09-18

Intent: Highlight the importance of improving the competitiveness of the life science industry in Europe::Outline the importance of the Biotech act in improving the competitiveness of the life science industry in Europe

Details: Ireland’s priorities for the 2026 Presidency of the Council of the European Union, including issues related to life sciences competitiveness

Methods
Meeting

Pfizer

15 officials
2026-09-18

Intent: Highlight the importance of the roll-out of an RSV National Immunisation Programme for older adults::To ensure that the burden of RSV disease among older adults, including acknowledged limitations in testing, surveillance and disease burden estimation, is appropriately considered in policy decision-making regarding the potential implementation of RSV vaccination through the National Immunisation Programme in Ireland.::To highlight the importance of prevention and adult vaccination in improving health outcomes for patients, healthcare systems, and society

Details: Expansion of the National Immunisation Programme to include RSV vaccination for older adults

Methods
Provide information materials for briefing event relating to RSV disease burden, healthy ageing and international approaches to immunisation. - MeetingEmailLetter

AerCap Holdings N.V.

6 officials
2026-05-12

Intent: Continued engagement and awareness of aircraft leasing industry matters.

Details: General exchange on aviation leasing industry and policy developments including taxation, tariffs/trade.

Methods
11 March 2026 - Meeting (general industry discussion) between AerCap (Aengus Kelly) and Taoiseach Micheal Martin. - Meeting13 January 2026 - Meeting between AerCap (Donal Handley, Risteard Sheridan) and DPO - Geraldine Byrne Nason. - Meeting23 January 2026 - Virtual Meeting between AerCap (Donal Handley) and DPO - Ethna Brogan. - Virtual Meeting

Ibec

1 official
2026-01-21

Intent: Communicate business priorities on EU-US trade as part of a BusinessEurope mission to Washington.

Details: Request for a meeting with Ambassador of Ireland to the United States of America Geraldine Byrne Nason

Methods
EmailMeeting

AerCap Holdings N.V.

3 officials
2026-01-20

Intent: Continued engagement and awareness of aircraft leasing industry matters.

Details: General exchange on policy developments including taxation, tariffs/trade.

Methods
11 November 2025 - Meeting between AerCap (Donal Handley, Risteard Sheridan) and DPO - Maeve von Heynitz. - Meeting13 October 2025 - Meeting between AerCap (Derek Goad) and DPO - Geraldine Byrne Nason. - Meeting18 December 2025 - Email correspondence between AerCap (Donal Handley) and DPO - Geraldine Byrne Nason. - Email

Bayer Limited

1 official
2025-09-21

Intent: Awareness of Bayer's Crop Science division and role of the company in St. Louis and the wider US.

Details: Participation in a roundtable discussion with the Irish Ambassador to the US, organised by Greater St Louis Inc., Missouri.

Methods
Meeting

Eli Lilly and Company

3 officials
2025-09-19

Intent: To highlight the complexity of global supply chains in the pharmaceutical industry and the risk of disruption those supply chains that tariffs may cause. ::To highlight the need for pro-business government policies that value innovation and support the continued strong footprint of innovative biopharma manufacturing in Ireland.

Details: Discuss the risks of potential tariffs on the complex global supply chains for innovative medicines

Methods
Virtual Meeting